[Apolipoproptein E-CI-CII gene cluster and its effect on serum lipid levels]

Chun-Hong Wang1, Xin Zhou, Qun Shi

  • 1School of Medicine, Wuhan University, Wuhan 430071, China.

Insights

Apolipoprotein (apo)E-CI-CII gene cluster frequencies in Chinese Hans were analyzed. ApoCII T1/2 genotype was linked to higher triglyceride levels, potentially explaining lower atherosclerosis rates in this population.

Area of Science:

  • Genetics
  • Biochemistry
  • Population Health

Background:

  • The apolipoprotein (apo)E-CI-CII gene cluster plays a role in lipid metabolism.
  • Understanding the genetic variations within this cluster is crucial for population-specific health assessments.

Purpose of the Study:

  • To determine the allele frequencies of the apoE-CI-CII gene cluster in the Han Chinese population.
  • To investigate the association between these gene polymorphisms and serum lipid levels.

Main Methods:

  • Genotyping of apoE, apoCI, and apoCII using PCR-based methods (multi-AMRS PCR, PCR-RFLP).
  • Serum lipid levels measured using an automatic chemistry analyzer.
  • Analysis of genotype distributions, allele frequencies, and linkage disequilibrium.

Main Results:

  • ApoE E3/3 (73.4%) was the most common genotype; rare genotypes (E2/2, E2/4, E4/4) were <1%.
  • ApoCI H1/1 (79.7%) and H2/2 (1.7%) frequencies were determined.
  • ApoCII allele frequencies were T1 (70.7%) and T2 (29.3%).
  • No association found between apoE or apoCI polymorphisms and plasma lipid levels.
  • The T1/2 genotype of ApoCII showed significantly higher triglyceride levels (P < 0.05) compared to T1/1.
  • No significant gender-based differences in genotype or allele frequencies were observed.

Conclusions:

  • The apoE-CI-CII gene cluster exhibits specific allele frequencies in the Han Chinese population.
  • ApoCII T1/2 genotype is associated with elevated triglyceride levels.
  • These findings may contribute to understanding the lower prevalence of atherosclerosis in China.
Abstract

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...